Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study. // Pathology - Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0344033826003560?dgcid=rss_sd_all
Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study. Pathology - Research and Practice. https://www.sciencedirect.com/science/article/pii/S0344033826003560?dgcid=rss_sd_all
“Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study.” Pathology - Research and Practice.
@article{article61640,
title = {Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study},
journal = {Pathology - Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0344033826003560?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....